Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient MiceFrédérique Dol-Gleizes, Françoise Bono, Andries J. Gilde et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 124
Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient MiceFrédérique Dol, Jean‐Marc Herbert, Catherine Cazaubon et al.|Journal of Cardiovascular Pharmacology|2001Cited by 93
Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.Jean‐Marc Herbert, Paul Schaeffer, Françoise Bono et al.|Journal of Clinical Investigation|1998Cited by 70
Coagulation Factor Xa Induces Endothelium-Dependent Relaxations in Rat AortaPaul Schaeffer, Jean‐Marc Herbert, Anne-Marie Marés et al.|Circulation Research|1997Cited by 30
Lesion Progression in apoE-Deficient Mice: Implication of Chemokines and Effect of the AT1 Angiotensin II Receptor Antagonist IrbesartanGeneviève Martin, Jean‐Marc Herbert, Frédérique Dol et al.|Journal of Cardiovascular Pharmacology|2004Cited by 18